Oliver Luxxe Assets LLC Decreases Holdings in Encompass Health Corporation $EHC

Oliver Luxxe Assets LLC lowered its holdings in Encompass Health Corporation (NYSE:EHC) by 12.0% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 57,282 shares of the company’s stock after selling 7,820 shares during the quarter. Encompass Health comprises 1.2% of Oliver Luxxe Assets LLC’s investment portfolio, making the stock its 26th biggest holding. Oliver Luxxe Assets LLC owned about 0.06% of Encompass Health worth $7,276,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in EHC. Forum Financial Management LP boosted its holdings in Encompass Health by 13.7% in the 3rd quarter. Forum Financial Management LP now owns 2,492 shares of the company’s stock valued at $317,000 after purchasing an additional 301 shares in the last quarter. State of Alaska Department of Revenue grew its holdings in shares of Encompass Health by 109.5% during the third quarter. State of Alaska Department of Revenue now owns 26,209 shares of the company’s stock worth $3,328,000 after buying an additional 13,698 shares in the last quarter. Nisa Investment Advisors LLC boosted its stake in Encompass Health by 30.4% in the 3rd quarter. Nisa Investment Advisors LLC now owns 21,409 shares of the company’s stock worth $2,719,000 after buying an additional 4,987 shares during the last quarter. Invested Advisors purchased a new position in shares of Encompass Health in the 3rd quarter worth $429,000. Finally, Citizens National Bank Trust Department purchased a new position in Encompass Health in the third quarter valued at approximately $26,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Stock Down 2.0%

EHC opened at $102.89 on Friday. The business has a 50 day moving average of $110.79 and a 200-day moving average of $116.99. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 0.76. The stock has a market capitalization of $10.35 billion, a price-to-earnings ratio of 19.45, a P/E/G ratio of 1.66 and a beta of 0.74. Encompass Health Corporation has a 1-year low of $90.67 and a 1-year high of $127.99.

Encompass Health (NYSE:EHC) last released its earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share (EPS) for the quarter. The company had revenue of $136.30 million for the quarter. Encompass Health had a net margin of 9.33% and a return on equity of 17.84%. As a group, sell-side analysts anticipate that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be issued a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Friday, January 2nd. Encompass Health’s dividend payout ratio (DPR) is presently 14.37%.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on EHC. Zacks Research cut Encompass Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 19th. KeyCorp raised their target price on shares of Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a report on Tuesday, September 16th. Barclays upped their price target on shares of Encompass Health from $141.00 to $150.00 and gave the stock an “overweight” rating in a research report on Thursday, October 30th. UBS Group raised their price target on shares of Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Thursday, October 2nd. Finally, Raymond James Financial raised Encompass Health to a “strong-buy” rating in a report on Friday, October 31st. Two equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $142.86.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post?acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end?of?life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.